Close
What would you like to look for?
Site search
Search filters

Memo Therapeutics AG Increases Series C Financing to CHF 45m

15 May 2024

Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.

Sale of Iconia Group to Deutsche Invest

12 February 2024

AFINUM and the management have sold Iconia Group to Deutsche Invest. Iconia Group is a global leader in point-of-purchase displays and packaging for the watch and jewelry industry. The transaction was completed on 31 January 2024.

GlycoEra AG increases its Series A Financing Round with investment by BMS

22 January 2024

GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional investment by Bristol Meyer Squibb (BMS).

VISCHER advises Bregal on the acquisition of Netrics Group

22 November 2023

Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...

LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

12 October 2023

LimmaTech Biologics AG announced the closing of a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.

Longevity startup Epiterna raises EUR 10million from Prima Materia

8 September 2023

Epiterna SA ("Epiterna") has raised EUR 10 million from Prima Materia, an investment firm founded by Spotify founder Daniel Ek and investor and early Spotify backer Shakil Khan.

Luciole Medical AG acquires Spiegelberg Group

3 July 2023

Luciole Medical, a Swiss medical technology company specialized in brain monitoring, acquires Spiegelberg GmbH & Co. KG (Spiegelberg), an established medical device company and provider of highly specialized devices and consumables for neurosurgery, from SHS Capital.

Rigeto Investors acquired prevention-center

28 April 2023

A group of investors advised by Munich-based Rigeto Unternehmerkapital GmbH ("Rigeto") has acquired prevention-center as an add-on to the Matignon Group.

VISCHER advised the sellers and the management on the sale of the Mimacom Flowable Group to Ardian

20 April 2023

The shareholders of the Mimacom Flowable Group ("MFG") have sold MFG to the private equity investment house Ardian, accompanied by a reinvestment of the management. The transaction was completed on 19 April 2023. Headquartered in...

ATANIS Biotech AG completes Financing Round

19 April 2023

ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.